Quick Takeaways
- LIFESCI CAPITAL, LLC filed SCHEDULE 13G for KALA BIO, Inc. Common Stock, $0.001 par value per share (KALA).
- Disclosed ownership: 7.9%.
- Date of event: 30 Dec 2025.
LIFESCI CAPITAL, LLC - 30 Dec 2025 SCHEDULE 13G Report for KALA BIO, Inc. Common Stock, $0.001 par value per share (KALA)
- Filing Manager
- LIFESCI CAPITAL, LLC
- Reporting Manager
- LifeSci Capital LLC
- Symbol
- KALA
- Shares outstanding
- 27,848,101 shares
- Disclosed Ownership
- 2,200,000 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Jan 2026, 08:00:05 UTC
- Date of event
- 30 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"LIFESCI CAPITAL, LLC disclosed 7.9% ownership in KALA BIO, Inc. Common Stock, $0.001 par value per share (KALA) on 30 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Jan 2026, 08:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LifeSci Capital LLC | 7.9% | 2,200,000 | 2,200,000 | 0 | /s/ Andrew McDonald | Andrew McDonald, Chief Executive Officer | |
| Andrew McDonald | 7.9% | 2,200,000 | 0 | 2,200,000 | /s/ Andrew McDonald | Andrew McDonald | |
| Michael Rice | 7.9% | 2,200,000 | 0 | 2,200,000 | /s/ Michael Rice | Michael Rice |